Proteomic analysis of radiation-induced senescent human fibroblasts revealed 178 proteins with 4-fold abundance changes, pinpointing decreased glucose metabolism, reduced ATP production, and declined chaperone proteins as hallmark survival features. Critically, inhibiting pyruvate dehydrogenase—the enzyme converting pyruvate to acetyl-CoA for cellular energy production—selectively killed senescent cells while sparing healthy ones. Combined inhibition of pyruvate dehydrogenase with Hsp90 chaperone protein enhanced this senolytic effect and improved physical function in aged mice. This metabolic vulnerability represents a paradigm shift in senolytic drug development. Previous senolytic approaches primarily targeted apoptosis pathways, but this research reveals senescent cells' unexpected dependence on specific metabolic machinery for survival. The selective toxicity suggests senescent cells operate under different bioenergetic constraints than healthy cells, creating exploitable therapeutic windows. However, translating pyruvate dehydrogenase inhibition to humans requires careful consideration, as this enzyme is essential for normal cellular respiration. The dual-target approach may provide better specificity, but determining optimal dosing and timing will be crucial to avoid disrupting healthy tissue metabolism while effectively clearing harmful senescent cells.